Lupin Ltd Drug Patent Portfolio
Lupin Ltd owns 1 orange book drug protected by 1 US patent Given below is the list of Lupin Ltd's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9233112 | Pharmaceutical compositions of cefixime | 14 Dec, 2028 | Active |
Lupin Ltd's Family Patents
Recently granted tentative Approvals to Lupin Ltd
These tentative approvals reflect continued regulatory progress across both innovative and generic submissions related to Lupin Ltd's portfolio.
Innovator tentative approvals
| Drug Name | Active Ingredient | Submission Type | Submission Category | Submission Date |
|---|---|---|---|---|
| Dolutegravir;lamivudine;tenofovir Alafenamide | Dolutegravir;lamivudine;tenofovir Alafenamide |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 4 - New Combination | 18 Jul, 2023 |
| Dolutegravir; Emtricitabine; Tenofovir Alafenamide | Dolutegravir;emtricitabine;tenofovir Alafenamide |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 4 - New Combination | 19 Jan, 2023 |
| Dolutegravir, Lamivudine And Tenofovir Disoproxil Fumarate | Dolutegravir; Lamivudine; Tenofovir Disoproxil Fumarate |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 4 - New Combination | 25 Jun, 2021 |
Generic tentative approvals
| Drug Name | Active Ingredient | Submission Type | Submission Category | Submission Date |
|---|---|---|---|---|
| Armodafinil | Armodafinil |
ORIG-2
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Not Applicable | 28 Nov, 2016 |
| Doxycycline | Doxycycline |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 29 Jul, 2013 |
| Irbesartan And Hydrochlorothiazide | Hydrochlorothiazide; Irbesartan |
ORIG-2
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Not Applicable | 27 Feb, 2013 |
Explore deeper patents analysis
Lupin Ltd Drug List
Given below is the complete list of Lupin Ltd's drugs and the patents protecting them.
1. Suprax
Suprax is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9233112 | Pharmaceutical compositions of cefixime |
14 Dec, 2028
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Suprax's drug page